CoreRx News and Resources

CDMO News

CoreRx Completes Acquisition of Societal CDMO

Pharmaceutical company CoreRx has completed its acquisition of Societal CDMO. The acquisition was achieved through a tender offer to purchase all issued and outstanding shares of Societal CDMO at a price of $1.10 per share. The tender offer expired as scheduled on April

Read More »
CDMO News

Societal CDMO to be Acquired by CoreRx

In order to expand its capabilities, CoreRx, Inc. has announced a definitive agreement to acquire Societal CDMO, Inc. (NASDAQ: SCTL), a contract development and manufacturing organisation (CDMO) known for tackling complex formulation and manufacturing challenges. The transaction is expected to close early in

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.